Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Regulatory News (HLN)

Share Price Information for Haleon (HLN)

Share Price is delayed by 15 minutes
Get Live Data
321.20    0.30 (0.09%)
Bid:
320.40
Ask:
320.50
Spread: 0.10 (0.031%)
Market Cap: £28.42b
HLN Live PriceLast checked at - London Stock Exchange

Intraday Haleon Share Chart

Director/PDMR Shareholding

19 May 2025 10:00

RNS Number : 1992J
Haleon PLC
19 May 2025
 

 

Haleon plc: Director/PDMR Shareholding 

 

​19 May 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").

 

On 16 May 2025, the Company received notification of the following transaction as detailed below.

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)

 

Name

 

Bláthnaid Bergin

 

 

Reason for the notification  

 

a)

 

Position/status

 

 

Independent Non-Executive Director - PDMR

b)

 

Initial notification /Amendment

 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

 

a)

 

Name

 

Haleon plc 

b)

 

LEI

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

 

Identification code

GB00BMX86B70

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares in the Company  

c)

 

Price(s) and volume(s)

Price(s) 

Volume(s) 

£4.0427

6,145

d)

 

Aggregated information

 N/A - single transaction

- Aggregated volume 

- Price 

e)

 

Date of the transaction

 

16 May 2025

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

 

For more information, please visit www.haleon.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIGDUIBBDGUC
Date   Source Headline
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20252:15 pmRNSDirector/PDMR Shareholding
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 202511:30 amRNS2025 Capital Markets Day
1st May 20259:00 amRNSTotal Voting Rights and Capital
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 202510:00 amRNSBoard Change
30th Apr 20257:05 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSHaleon 2025 Q1 Trading Statement
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 202510:00 amRNSIncrease ownership of China JV to 100%
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 202510:00 amRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20253:00 pmRNSNotice of Annual General Meeting (AGM)
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 202512:00 pmRNSTotal Voting Rights and Capital
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSCommencement of Share Buyback Programme
21st Mar 20256:00 pmRNSHolding(s) in Company
21st Mar 20253:30 pmRNSDirector/PDMR Shareholding
21st Mar 202511:15 amRNSCompletion of off-market purchase and Total Voting
21st Mar 20257:00 amRNSPublication of Annual Report and Form 20-F 2024
20th Mar 20253:30 pmRNSHolding(s) in Company
19th Mar 20256:00 pmRNSHaleon
19th Mar 20257:01 amRNSUpdate on off-market purchase alongside Pfizer
19th Mar 20257:00 amRNSPRICING OF OFFERING IN HALEON PLC BY PFIZER INC.
18th Mar 20254:51 pmRNSProposed off-market purchase alongside Pfizer
18th Mar 20254:44 pmRNSPROPOSED OFFERING IN HALEON PLC BY PFIZER INC.
17th Mar 20253:15 pmRNSDirector/PDMR Shareholding
12th Mar 20251:45 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSHaleon Preliminary 2024 Full Year Results
26th Feb 20255:39 pmRNSHolding(s) in Company
25th Feb 20253:00 pmRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.